Are Nitta Gelatin India Ltd latest results good or bad?

1 hour ago
share
Share Via
Nitta Gelatin India Ltd's latest results are strong, with net sales of ₹161.73 crores (up 25.24% year-on-year) and a net profit of ₹34.08 crores (up 73.61 year-on-year), indicating robust growth and improved operational efficiency. The company also boasts a high return on equity of 19.54% and a virtually debt-free balance sheet.
Nitta Gelatin India Ltd's latest financial results for the quarter ending March 2026 reflect a significant operational performance, showcasing robust growth and efficiency. The company reported net sales of ₹161.73 crores, which represents a year-on-year growth of 25.24% and a sequential increase of 8.02% from the previous quarter. This marks the highest quarterly revenue in the company's history, indicating strong market demand and effective sales strategies.
Net profit for the quarter reached ₹34.08 crores, reflecting a substantial year-on-year increase of 73.61% and a sequential growth of 33.28%. This impressive profit growth is attributed to the company's ability to enhance its operating margins, which expanded to 28.07%, up from 18.06% a year ago, demonstrating improved operational leverage and cost management. The company's operational efficiency is further underscored by its return on equity (ROE) of 19.54%, which is significantly above industry averages, indicating effective capital utilization. Additionally, Nitta Gelatin India maintains a virtually debt-free balance sheet, with negligible interest costs, providing it with a competitive edge in the specialty chemicals sector. Overall, the results indicate that Nitta Gelatin India is experiencing a strong upward trajectory in profitability and operational efficiency. The company saw an adjustment in its evaluation, reflecting its solid performance metrics and market positioning. The consistent growth in sales and profits, alongside strong margins, highlights the company's sustainable business momentum and operational excellence in the gelatin and collagen peptide markets.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News